Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial

OBJECTIVE: this triple-masked controlled trial aimed to assess the effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in obese children and adolescents. METHODS: the study comprised 50 participants, aged 10 to16 years, who were randomly assigned into two groups of equal number. In this 12-week trial, one group received oral vitamin D (300,000 IU) and the other group received placebo. Cardiometabolic risk factors, insulin resistance, and a continuous value of metabolic syndrome (cMetS) were determined. Statistical analysis was conducted after adjustment for covariate interactions. RESULTS: overall, 21 patients in the vitamin D group and 22 in the placebo group completed the trial. No significant difference was observed in the baseline characteristics of the two groups. After the trial, in the vitamin D group, serum insulin and triglyceride concentrations, as well as HOM -IR and C-MetS decreased significantly, both when compared with the baseline and with the placebo group. No significant difference was observed when comparing total cholesterol, LDL-C, HDL-C, fasting blood glucose, and blood pressure. CONCLUSION: the present findings support the favorable effects of vitamin D supplementation on reducing insulin resistance and cardiometabolic risk factors in obese children.

Saved in:
Bibliographic Details
Main Authors: Kelishadi,Roya, Salek,Shadi, Salek,Mehdi, Hashemipour,Mahin, Movahedian,Mahsa
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Pediatria 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000100028
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0021-75572014000100028
record_format ojs
spelling oai:scielo:S0021-755720140001000282015-08-28Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trialKelishadi,RoyaSalek,ShadiSalek,MehdiHashemipour,MahinMovahedian,Mahsa Vitamin D Metabolic syndrome Insulin resistance Children and adolescents OBJECTIVE: this triple-masked controlled trial aimed to assess the effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in obese children and adolescents. METHODS: the study comprised 50 participants, aged 10 to16 years, who were randomly assigned into two groups of equal number. In this 12-week trial, one group received oral vitamin D (300,000 IU) and the other group received placebo. Cardiometabolic risk factors, insulin resistance, and a continuous value of metabolic syndrome (cMetS) were determined. Statistical analysis was conducted after adjustment for covariate interactions. RESULTS: overall, 21 patients in the vitamin D group and 22 in the placebo group completed the trial. No significant difference was observed in the baseline characteristics of the two groups. After the trial, in the vitamin D group, serum insulin and triglyceride concentrations, as well as HOM -IR and C-MetS decreased significantly, both when compared with the baseline and with the placebo group. No significant difference was observed when comparing total cholesterol, LDL-C, HDL-C, fasting blood glucose, and blood pressure. CONCLUSION: the present findings support the favorable effects of vitamin D supplementation on reducing insulin resistance and cardiometabolic risk factors in obese children. info:eu-repo/semantics/openAccessSociedade Brasileira de PediatriaJornal de Pediatria v.90 n.1 20142014-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000100028en10.1016/j.jped.2013.06.006
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Kelishadi,Roya
Salek,Shadi
Salek,Mehdi
Hashemipour,Mahin
Movahedian,Mahsa
spellingShingle Kelishadi,Roya
Salek,Shadi
Salek,Mehdi
Hashemipour,Mahin
Movahedian,Mahsa
Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
author_facet Kelishadi,Roya
Salek,Shadi
Salek,Mehdi
Hashemipour,Mahin
Movahedian,Mahsa
author_sort Kelishadi,Roya
title Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
title_short Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
title_full Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
title_fullStr Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
title_full_unstemmed Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
title_sort effects of vitamin d supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
description OBJECTIVE: this triple-masked controlled trial aimed to assess the effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in obese children and adolescents. METHODS: the study comprised 50 participants, aged 10 to16 years, who were randomly assigned into two groups of equal number. In this 12-week trial, one group received oral vitamin D (300,000 IU) and the other group received placebo. Cardiometabolic risk factors, insulin resistance, and a continuous value of metabolic syndrome (cMetS) were determined. Statistical analysis was conducted after adjustment for covariate interactions. RESULTS: overall, 21 patients in the vitamin D group and 22 in the placebo group completed the trial. No significant difference was observed in the baseline characteristics of the two groups. After the trial, in the vitamin D group, serum insulin and triglyceride concentrations, as well as HOM -IR and C-MetS decreased significantly, both when compared with the baseline and with the placebo group. No significant difference was observed when comparing total cholesterol, LDL-C, HDL-C, fasting blood glucose, and blood pressure. CONCLUSION: the present findings support the favorable effects of vitamin D supplementation on reducing insulin resistance and cardiometabolic risk factors in obese children.
publisher Sociedade Brasileira de Pediatria
publishDate 2014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000100028
work_keys_str_mv AT kelishadiroya effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial
AT salekshadi effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial
AT salekmehdi effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial
AT hashemipourmahin effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial
AT movahedianmahsa effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial
_version_ 1756375887868067840